Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research
暂无分享,去创建一个
Johannes W. Dietrich | R. Hoermann | J. E. Midgley | Gabi Landgrafe-Mende | Evelin Wiora | Apostolos Chatzitomaris | Harald H. Klein | John E. M. Midgley | Rudolf Hoermann | Apostolos Chatzitomaris | H. Klein | Gabi Landgrafe-Mende | Gabi Landgrafe-Mende | Evelin Wiora | J. Midgley
[1] D. Girelli,et al. Low selenium status in the elderly influences thyroid hormones. , 1995, Clinical science.
[2] O. Koulouri,et al. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under‐replacement with levothyroxine , 2011, Clinical endocrinology.
[3] J. DiStefano,et al. TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence. , 2009, Thyroid : official journal of the American Thyroid Association.
[4] Johannes W. Dietrich,et al. Variation in the biochemical response to l-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency , 2015, Endocrine connections.
[5] S. Shalet,et al. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index , 2009, Clinical endocrinology.
[6] J. W. Dietrich,et al. THYROTROPIC FEEDBACK CONTROL: EVIDENCE FOR AN ADDITIONAL ULTRASHORT FEEDBACK LOOP FROM FRACTAL ANALYSIS , 2004, Cybern. Syst..
[7] R. Utiger,et al. Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. , 1967, The Journal of clinical endocrinology and metabolism.
[8] Ho-Cheol Kang,et al. A case of masked toxic adenoma in a patient with non-thyroidal illness , 2014, BMC Endocrine Disorders.
[9] Orit Shechtman,et al. The Coefficient of Variation as an Index of Measurement Reliability , 2013 .
[10] P. Scriba,et al. Normalisierung des T3/T4-Quotienten im Serum bei Struma-Patienten unter Kaliumjodid: Ein Beispiel der Autoregulation der Schilddrüse , 2005, Klinische Wochenschrift.
[11] A. Miyauchi,et al. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. , 2005, Endocrine journal.
[12] H. Liu,et al. Metabolic Characteristics in Obese Patients Complicated by Mild Thyroid Hormone Deficiency , 2016, Hormone and Metabolic Research.
[13] Melvin Khee-Shing Leow,et al. A novel minimal mathematical model of the hypothalamus-pituitary-thyroid axis validated for individualized clinical applications. , 2014, Mathematical biosciences.
[14] Johannes W. Dietrich,et al. TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis , 2012, Journal of thyroid research.
[15] H. Candiloros,et al. The serum triiodothyronine to thyroxine (T3/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy. , 2004, Hormones.
[16] P. Laurberg,et al. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. , 2002, The Journal of clinical endocrinology and metabolism.
[17] Jie-shou Li,et al. Nonthyroidal Illness Syndrome: Is It Far Away From Crohn’s Disease? , 2013, Journal of clinical gastroenterology.
[18] C. Spencer,et al. Current status and performance goals for serum thyrotropin (TSH) assays. , 1996, Clinical chemistry.
[19] Johannes W. Dietrich,et al. Homeostatic Control of the Thyroid–Pituitary Axis: Perspectives for Diagnosis and Treatment , 2015, Front. Endocrinol..
[20] K. Burman,et al. Subclinical hyperthyroidism: controversies in management. , 2002, American family physician.
[21] R. Hoermann,et al. Reference range for thyrotropin , 2015, Nuklearmedizin.
[22] P. Walfish. T3/T4 RATIO IN THYROID DISEASE , 1978, The Lancet.
[23] L. Wartofsky. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence , 2002, Expert opinion on pharmacotherapy.
[24] J. DiStefano,et al. TSH regulation dynamics in central and extreme primary hypothyroidism. , 2010, Thyroid : official journal of the American Thyroid Association.
[25] F. Frasca,et al. Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients , 2011, PloS one.
[26] N. Amino,et al. T3/T4 RATIO IN THYROID DISEASE , 1979, The Lancet.
[27] K. Pantalone,et al. Approach to a low TSH level: Patience is a virtue , 2010, Cleveland Clinic Journal of Medicine.
[28] A. Villringer,et al. Patient-reported outcomes in adequately treated hypothyroidism – insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ , 2013, Health and Quality of Life Outcomes.
[29] Johannes W. Dietrich,et al. Derivation of a multivariate reference range for pituitary thyrotropin and thyroid hormones: diagnostic efficiency compared with conventional single-reference method. , 2016, European journal of endocrinology.
[30] J. DiStefano,et al. On model and data requirements for determining the bioavailability of oral therapeutic agents: application to gut absorption of thyroid hormones. , 1979, The American journal of physiology.
[31] Johannes W. Dietrich,et al. Of rats and men: thyroid homeostasis in rodents and human beings. , 2015, The lancet. Diabetes & endocrinology.
[32] H. Pijl,et al. Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism , 2015, Scientific Reports.
[33] C. Randall. Letter: Temporary paralysis in childhood after influenza B. , 1975, Lancet.
[34] Johannes W. Dietrich,et al. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment , 2014, Clinical endocrinology.
[35] Johannes W. Dietrich,et al. Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling , 2015, European Thyroid Journal.
[36] A. Rydzewski,et al. Influence of low protein diet on nonthyroidal illness syndrome in chronic renal failure , 2005, Endocrine.
[37] C. Dayan,et al. Hypothyroidism and Depression , 2013, European Thyroid Journal.
[38] R Bianchi,et al. Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis. , 1990, The American journal of physiology.
[39] W. Wiersinga. Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism , 2014, Nature Reviews Endocrinology.
[40] A. Miyauchi,et al. 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. , 2008, The Journal of clinical endocrinology and metabolism.
[41] D. Rennie,et al. Thyroid storm. , 1997, JAMA.
[42] Johannes W. Dietrich,et al. SPINA-THYR: A NOVEL SYSTEMS THEORETIC APPROACH TO DETERMINE THE SECRETION CAPACITY OF THE THYROID GLAND , 1997 .
[43] E B Stear,et al. Neuroendocrine control of thyroid secretion in living systems: a feedback control system model. , 1968, The Bulletin of mathematical biophysics.
[44] F. Matsuzuka,et al. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. , 1984, Annals of internal medicine.
[45] M. Berger,et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial , 2001, Intensive Care Medicine.
[46] Volker H. Franz,et al. Ratios: A short guide to confidence limits and proper use , 2007, 0710.2024.
[47] A. Bianco,et al. The History and Future of Treatment of Hypothyroidism , 2016, Annals of Internal Medicine.
[48] M. Falchi,et al. Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort , 2008, Clinical endocrinology.
[49] K. Nakatani,et al. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis. , 1981, The Journal of clinical endocrinology and metabolism.
[50] Mario Plebani,et al. Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value , 2015, Clinical chemistry and laboratory medicine.
[51] Johannes W. Dietrich,et al. A novel de novo mutation in the thyroid hormone receptor-beta gene , 2015 .
[52] Victor M Montori,et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. , 2011, Thyroid : official journal of the American Thyroid Association.
[53] J. DiStefano,et al. Simulation of post-thyroidectomy treatment alternatives for triiodothyronine or thyroxine replacement in pediatric thyroid cancer patients. , 2012, Thyroid : official journal of the American Thyroid Association.
[54] E. Fliers,et al. Pilot study on the assessment of the setpoint of the hypothalamus-pituitary-thyroid axis in healthy volunteers. , 2010, European journal of endocrinology.
[55] J. DiStefano. A model of the normal thyroid hormone glandular secretion mechanism. , 1969, Journal of theoretical biology.
[56] A. Bianco,et al. Defending plasma T3 is a biological priority , 2014, Clinical endocrinology.
[57] J. Hennessey. Levothyroxine dosage and the limitations of current bioequivalence standards , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[58] Johannes W. Dietrich,et al. Das Refeeding-Syndrom - Eine Literaturübersicht Refeeding Syndrome: A Review of the Literature , 2014 .
[59] Johannes W. Dietrich,et al. Integration of Peripheral and Glandular Regulation of Triiodothyronine Production by Thyrotropin in Untreated and Thyroxine-Treated Subjects , 2015, Hormone and Metabolic Research.
[60] Johannes W. Dietrich,et al. [Absorption, transport and bio-availability of iodothyronines]. , 2008, Deutsche medizinische Wochenschrift.
[61] P. Laurberg,et al. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study. , 2013, European journal of endocrinology.
[62] S. Rohrer,et al. Das Refeeding-Syndrom – Eine Literaturübersicht , 2014, Zeitschrift für Gastroenterologie.
[63] Johannes W. Dietrich,et al. The AQUA-FONTIS study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome , 2008, BMC endocrine disorders.
[64] Johannes W. Dietrich,et al. Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment? , 2013, European journal of endocrinology.
[65] P. Macchia,et al. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. , 1999, The Journal of clinical endocrinology and metabolism.
[66] P. Laurberg. Mechanisms governing the relative proportions of thyroxine and 3,5,3'-triiodothyronine in thyroid secretion. , 1984, Metabolism: clinical and experimental.
[67] Xiuwen Wu,et al. Nonthyroidal illness syndrome in enterocutaneous fistulas. , 2013, American journal of surgery.
[68] A. Bianco,et al. New insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism. , 2015, The lancet. Diabetes & endocrinology.
[69] J. DiStefano,et al. L-T4 bioequivalence and hormone replacement studies via feedback control simulations. , 2006, Thyroid : official journal of the American Thyroid Association.
[70] Melvin Khee-Shing Leow,et al. Hypothalamus–Pituitary–Thyroid Feedback Control: Implications of Mathematical Modeling and Consequences for Thyrotropin (TSH) and Free Thyroxine (FT4) Reference Ranges , 2014, Bulletin of mathematical biology.
[71] Robert B. DarofL. Supplements , 1992, Neurology.
[72] R. Casamitjana,et al. Serum free triiodothyronine (T3) to free thyroxine (T4) ratio in treated central hypothyroidism compared with primary hypothyroidism and euthyroidism. , 2011, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.
[73] Johannes W. Dietrich,et al. Physiological states and functional relation between thyrotropin and free thyroxine in thyroid health and disease: in vivo and in silico data suggest a hierarchical model , 2013, Journal of Clinical Pathology.
[74] K. Muroya,et al. The ratio of serum free triiodothyronine to free thyroxine in children: a retrospective database survey of healthy short individuals and patients with severe thyroid hypoplasia or central hypothyroidism , 2015, Thyroid Research.
[75] S. Fan,et al. MON-P112: Low Triiodothyronine Syndrome in Patients with Radiation Enteritis: Risk Factors and Clinical Outcomes an Observational Study , 2016 .
[76] C. Doré,et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. , 2002, The American journal of medicine.
[77] Simon X. Han,et al. THYROSIM App for Education and Research Predicts Potential Health Risks of Over-the-Counter Thyroid Supplements. , 2016, Thyroid : official journal of the American Thyroid Association.
[78] T. Wilkin,et al. The behavior of the triiodothyronine/thyroxine (T3/T4) ratio in normal individuals, and its implications for the regulation of euthyroidism , 1984, Journal of endocrinological investigation.
[79] J. DiStefano,et al. Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis. , 2008, Thyroid : official journal of the American Thyroid Association.